熱門資訊> 正文
加拿大自然资源部非GAAP每股收益为2.19加元;提高2026财年产量指引
2026-08-06 17:09
- Canadian Natural Resources press release (CNQ): Q2 Non-GAAP EPS of C$2.19.
- "On a total corporate basis, we achieved record quarterly production of approximately 1,677,000 BOE/d in Q2/26, resulting in year-over-year growth of approximately 256,000 BOE/d or 18% from Q2/25 levels."
- Total quarterly liquids production was also a record at approximately 1,249,000 bbl/d, of which 67% was high-value SCO, light crude oil and NGLs.
- "We also achieved record quarterly liquids production of approximately 338,000 bbl/d in our North American Conventional E&P assets, representing an increase of 67,000 bbl/d or 25% from Q2/25 levels."
- "We are increasing our 2026 annual production guidance range for the second time this year to 1,637 MBOE/d and 1,682 MBOE/d, a 20 MBOE/d increase at mid-point from the previous guidance range of 1,615 MBOE/d and 1,665 MBOE/d. We remain focused on executing our prudent and efficient 2026 capital program as our operating capital remains unchanged at approximately $6.0 billion, before net acquisition costs. "
推薦文章
港股周報 | 黃金股狂飆！靈寶黃金周升24%；段永平「被動減持」泡泡瑪特；藥明康德升近20%創新高
一周財經日曆 | 重磅財報周！騰訊、Lumentum、中芯國際輪番登場！美國7月CPI攜零售數據來襲
8月8日外盤頭條：伊朗內部辯論霍爾木茲協議措辭 非農爆冷削弱加息預期 SpaceX將自建發電廠保障電力供應
Palantir股價將創下自2024年以來最佳單周表現，該股已不再是AI領域的失意者
7月非農就業數據走弱，支持美聯儲維持利率不變，但加息選項並未徹底排除
美股前瞻 | 聚焦20：30！市場靜候7月非農數據；特朗普政府擬加碼佈局關鍵礦產；應用光電計劃大規模擴產，光通信盤前集體飆升
港股異動 | 創新葯概念再度走強，再鼎新葯勁升14%，Q2產品收入環比增長11%；藥明生物升逾5%，百濟神州升逾3%
港股異動 | AI硬件股多數上漲，建滔積層板、勝宏科技漲逾5%，兆易創新漲逾3%；南方兩倍做多海力士跌逾9%
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
